Perceptive Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-960,000
| Closed | -$109M | – | 114 |
|
|
2022
Q4 | $109M | Buy |
+960,000
| New | +$109M | 3.07% | 7 |
|
|
2022
Q2 | – | Sell |
-1,357,903
| Closed | -$143M | – | 142 |
|
|
2022
Q1 | $143M | Sell |
1,357,903
-380,237
| -22% | -$40M | 2.86% | 9 |
|
|
2021
Q4 | $187M | Sell |
1,738,140
-218,800
| -11% | -$23.6M | 2.89% | 7 |
|
|
2021
Q3 | $214M | Sell |
1,956,940
-28,062
| -1% | -$3.07M | 3.11% | 8 |
|
|
2021
Q2 | $186M | Sell |
1,985,002
-65,000
| -3% | -$6.09M | 2.41% | 8 |
|
|
2021
Q1 | $189M | Sell |
2,050,002
-1,034,040
| -34% | -$95.2M | 2.39% | 10 |
|
|
2020
Q4 | $226M | Buy |
+3,084,042
| New | +$226M | 2.42% | 9 |
|
|
2016
Q2 | – | Sell |
-350,000
| Closed | -$5.8M | – | 210 |
|
|
2016
Q1 | $5.8M | Buy |
+350,000
| New | +$5.8M | 0.51% | 48 |
|
|
2014
Q2 | – | Sell |
-9,120
| Closed | -$138K | – | 151 |
|
|
2014
Q1 | $138K | Buy |
+9,120
| New | +$138K | 0.01% | 105 |
|